SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-097200
Filing Date
2021-07-29
Accepted
2021-07-29 06:18:36
Documents
64
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q inva-20210630x10q.htm   iXBRL 10-Q 1874709
2 EXHIBIT-31.1 inva-20210630xex31d1.htm EX-31.1 10126
3 EXHIBIT-31.2 inva-20210630xex31d2.htm EX-31.2 10067
4 EXHIBIT-32 inva-20210630xex32.htm EX-32 16067
  Complete submission text file 0001104659-21-097200.txt   7583538

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA inva-20210630.xsd EX-101.SCH 44156
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE inva-20210630_cal.xml EX-101.CAL 65224
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE inva-20210630_def.xml EX-101.DEF 204685
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE inva-20210630_lab.xml EX-101.LAB 411784
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inva-20210630_pre.xml EX-101.PRE 350184
10 EXTRACTED XBRL INSTANCE DOCUMENT inva-20210630x10q_htm.xml XML 1581478
Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30319 | Film No.: 211124700
SIC: 2834 Pharmaceutical Preparations